Category: Johnson & JohnsonSyndicate content

J&J's DePuy inks robotic surgery partnership with Blue Belt

September 17, 2014 by Arezu Sarvestani

Johnson & Johnson's DePuy Synthes subsidiary pairs its SIGMA HP partial knee with Blue Belt Technologies' Navio robot-assisted surgical system.

J&J's DePuy inks robotic surgery partnership with Blue Belt

Indian media accuse Medtronic, Abbott, J&J of price-hikes, bribery

September 16, 2014 by Arezu Sarvestani

Media reports in India claim that some of medtech's biggest companies are looking the other way when their Indian distributors hike prices and bribe doctors to use their drug-eluting stents.

India's news cries price hiking, bribery for Medtronic, Abbott, J&J stents

Some of medtech's biggest players are getting a beating in the Indian media, where reports this week accused them of turning a blind eye to unethical behavior from their distributors in the country.

Another J&J exec pressed in lawsuit over Pinnacle hip implant

September 16, 2014 by Brad Perriello

The plaintiff's lawyer in the 1st product liability trial over DePuy's Pinnacle hip replacement grills another Johnson & Johnson executive, worldwide clinical research vice president Pamela Plouhar, the at DePuy, over the metal-on-metal implants.

Another J&J exec pressed in lawsuit over Pinnacle hip implant

Cordis brings Incraft AAA stent graft to Europe and Canada

September 10, 2014 by Arezu Sarvestani

Johnson & Johnson subsidiary Cordis Corp. takes its Incraft stent graft system to Europe and Canada for treatment of patients with infrarenal abdominal aortic aneurysms.

Cordis brings Incraft AAA stent graft to Europe and Canada

Johnson & Johnson (NYSE:JNJ) subsidiary Cordis is taking its Incraft AAA stent abroad after winning regulatory approvals to market the device in Europe and Canada.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Ex-ArthroCare execs face hefty prison sentences | Medtech legal news for the week of September 8, 2014

September 8, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Ex-ArthroCare CEO Baker draws 20 years; Smith & Nephew settles whistleblower lawsuit for $8M; Secant Medical escapes pelvic mesh cases; Bellwether trial kicks off for DePuy's Pinnacle hip implant; J&J, Boston Scientific, others can't shake Philly pelvic mesh mass tort

Ex-ArthroCare CEO Baker draws 20 years

September 2, 2014 by Brad Perriello

Ex-ArthroCare CEO Baker draws 20 years

J&J loses $3.3M verdict in pelvic mesh injury lawsuit

September 5, 2014 by Arezu Sarvestani

A federal court finds Johnson & Johnson's Ethicon subsidiary guilty of selling a defective transvaginal implant and of failing to warn patients about the device's risks.

J&J loses $3.3M verdict in pelvic mesh injury lawsuit

Johnson & Johnson's (NYSE:JNJ) Ethicon subsidiary has vowed to file an appeal after a federal jury found the company guilty of selling defective medical devices.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp